Migrating with myosin VI.

Migrating with myosin VI. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Migrating with myosin VI. Abstract Text:

Migrating with myosin VI. Publishing Authors By Initials

For similar biological factors: biological markers: tumor markers, biological research abstracts see: biological factors: biological markers: tumor markers, biological research

PUBMED ID PMID:

MEDLINE DATE:

Migrating with myosin VI. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: The American journal of pathology

VOLUME: 169

Page Numbers: 1523-6

Journal Abbreviation: Am. J. Pathol.

ISSN: 0002-9440

DAY: 3

MONTH: Nov

YEAR: 2006

Migrating with myosin VI. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 370502

Migrating with myosin VI. Keywords Mesh Terms:

KEYWORDS: Tumor Markers, Biological

MESH TERMS: metabolism

Chemical & Substance for Abstract: Migrating with myosin VI. Information

Substance Name: myosin VI

Registry Number: 0

Grant and Affiliation Information for Migrating with myosin VI.

AFFILIATION: Fred Hutchinson Cancer Research Center, Program in Cancer Biology, Division of Public Health Sciences, 1100 Fairview Avenue North, M5-A864, Seattle, WA 98109, USA. bknudsen@fhcrc.org

Country: United States

AGENCY: United States NCI

GRANT: P30CA015704

ACRONYM: CA

MEDLINETA: Am J Pathol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Migrating with myosin VI Related Publications

• Age Modifies the Pituitary TSH Response to Thyroid Failure.
• Bisphenol A facilitates bypass of androgen ablation therapy in prostate cancer.
• Discourses of agency and the search for the authentic self: The case of mood-modifying medicines.
• Gingival epithelial cells heterozygous for Toll-like receptor 4 polymorphisms Asp299Gly and Thr399ile are hypo-responsive to Porphyromonas gingivalis.
• Impact of differential cyclin D1 expression and localisation in prostate cancer.
• Improved parameter estimation for systems with an experimentally located Hopf bifurcation.
• Integrative database management for mouse development: systems and concepts.
• Loss of RB compromises specific heterochromatin modifications and modulates HP1alpha dynamics.
• Migrating with myosin VI.
• Mitogenic action of the androgen receptor sensitizes prostate cancer cells to taxane-based cytotoxic insult.
• Neuroimaging of the serotonin reuptake site requires high-affinity ligands.
• Patterns of organization and management in private and public substance abuse treatment programs.
• Phototoxic furanocoumarins.
• Placental perfusion - a human alternative.
• Psychiatry and torture.
• RB activity alters checkpoint response and chemosensitivity in lung cancer lines.
• RB loss abrogates cell cycle control and genome integrity to promote liver tumorigenesis.
• RB loss promotes aberrant ploidy by deregulating levels and activity of DNA replication factors.
• Regulation of cell proliferation in a stratified culture system of epithelial cells from prostate tissue.
• Regulation of global gene expression in the bone marrow microenvironment by androgen: androgen ablation increases insulin-like growth factor binding protein-5 expression.
• Reprogramming of genetic networks during initiation of the Fetal Alcohol Syndrome.
• Retinoblastoma tumor suppressor status is a critical determinant of therapeutic response in prostate cancer cells.
• SWI/SNF activity is required for the repression of deoxyribonucleotide triphosphate metabolic enzymes via the recruitment of mSin3B.
• Saint Lucia revisited.
• The human placenta - An alternative for studying foetal exposure.
• Tryptophane-205 of human topoisomerase I is essential for camptothecin inhibition of negative but not positive supercoil removal.
• Unique bisphenol A transcriptome in prostate cancer: novel effects on ERbeta expression that correspond to androgen receptor mutation status.
• Variability of estimated binding parameters.
• [Not Available.]
• [Not Available.]